Review Series - June 30, 2016

This six-part series, written by leading experts in the field of cell-based immunotherapy, presents three articles discussing the state of the art of chimeric antigen receptor T-cell therapies and their toxicities and three additional articles that highlight other new immunotherapeutic approaches, including cellular therapies to treat post–hematopoietic stem cell transplantation viral infections, natural killer cell therapies for acute leukemia, and the use of gene-modified T cells to block immune evasion in hematologic malignancies.





See a full listing of the Blood Review Series here